Management of Diabetic Nephropathy
Patient Education and Immediate Management
- For a non-compliant diabetic patient with elevated creatinine and multiple comorbidities, immediate reinitiation of renin-angiotensin system inhibitors (ACEi or ARB) at the highest tolerated dose is essential, along with comprehensive education about diabetic nephropathy and its management, as recommended by the American College of Cardiology 1, 2
- The ordered tests (24-hour creatinine, complete urinalysis, albumin/creatinine ratio) will help assess the current severity of kidney damage, according to the American Diabetes Association 1
Comprehensive Treatment Approach
Blood Pressure Management
- Target blood pressure should be <130/80 mmHg, as recommended by the American Heart Association 5
- RAS inhibitors (ACEi or ARB) are first-line agents for patients with diabetes, hypertension, and albuminuria, according to the American College of Cardiology 2, 4
Glycemic Control
- For patients with type 2 diabetes and eGFR ≥20 ml/min/1.73 m², recommend SGLT2 inhibitors which provide kidney protection, as suggested by the European Association for the Study of Diabetes 2, 6
- Metformin may be used in combination with SGLT2 inhibitors when eGFR is ≥30 ml/min/1.73 m², according to the American Diabetes Association 3, 7
Additional Interventions
- Lipid management with statins should be considered for all patients with diabetic nephropathy, as recommended by the American College of Cardiology 1
- Dietary modifications including moderate protein intake (<0.8 g/kg/day) and reduced sodium intake (<2.0 g/day) are recommended by the National Kidney Foundation 8
Monitoring and Follow-up
- Monitor serum creatinine, potassium, and urine albumin/creatinine ratio regularly, as suggested by the American Society of Nephrology 1, 2
- Hyperkalemia associated with ACEi or ARB can often be managed without stopping these essential medications, according to the European Renal Association 1, 6
Addressing Medication Non-compliance
- Discuss specific barriers to medication adherence (cost, side effects, complexity of regimen) and consider simplified medication regimens when possible, as recommended by the American College of Physicians 4, 9